Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1994-12-07
2000-04-18
Wortman, Donna C.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 78, 435 6, 436501, C12Q 170, G01N 3353, G01N 33566
Patent
active
06051373&
ABSTRACT:
Disclosed is a method for screening for inhibitors of Hepatitis B Virus pX activity. The method involves contacting a test compound with (I) the pX protein of HBV, (ii) a transcription factor comprising the bZIP domain, or fragments that comprise a minimal a bZIP domain, and (iii) an oligoduplex comprising a target DNA sequence of the transcription factor to form a test mixture. After incubating the test mixture under appropriate conditions and for a sufficient time to allow pX-mediated dimerization and DNA binding of the transcription factor to occur, the level of DNA binding of the transcription factor in each test mixture is determined. A test compound is considered to be any compound that causes a decrease in the level of DNA binding in the test mixture relative to the level of DNA binding in control mixtures.
REFERENCES:
Avantaggiati et al., "The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements", Oncogene 8, 1567-1574, 1993.
Kohler et al., "Towards Routine Diagnosis of Hepatitis B Virus DNA", Clin. Chem. 39, 1185, 1993.
Alber, Curr.Biol. 3:182, 1993.
Angel et al., Biochim.Biophys. Acta 1072:129, 1991.
Baum, C&EN, Feb. 7, 1994, pp. 20-26.
Benn et al., Proc.Natl.Acad.Sci.USA. 91:10350-10354, 1994.
Burley, Curr.Opin.Struc.Biol. 4:3-11, 1994.
Busch et al., Trends Gen. 6:36, 1990.
De-Medina et al., Virol. 202:401-407, 1994.
Ellenberger, Curr.Opin.Struc.Biol. 4:12, 1994.
E. Harlow & D. Lane, Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, 1988.
Karin, Trends Gen. 5:65, 1989.
Kwee et al., J. Virol. 66:4382, 1992.
Maguire et al., Science 252:842-844, 1991.
Natoli et al., Mol.Cell.Biol. 14:989-998, 1994.
O'Neil et al., Science 249:774, 1990.
Patel et al., Proc.Natl.Acad.Sci.USA 91:7360, 1994.
Ponsetto et al., Hepatology 14:16-23, 1991.
Quadri, I. et al., Proc.Natl.Acad.Sci. USA, 92:1003-1007, 1995.
Sells et al., J. Virol. 62:2836, 1988.
Sells et al., Proc.Natl.Acad.Sci.USA 84:1005, 1987.
Takada et al., Oncogene 9:341-348, 1994.
Ziff, Trends Gen. 6:69, 1990.
Zola, Monoclonal Antibodies: A Manual of Techniques, CRC Press, Inc., Boca Raton, Florida, 1987.
Faktor et al., Oncogene, 5(6):867-872, Jun. 6, 1990.
Wagner et al., Science, 262:395-399, Oct. 15, 1993.
Williams et al., PNAS, 92(9):3819-3823.
Database WPI, Derwent Publication, Abstract No. 93-303964, Jul. 8, 1993.
Green Michael R.
Lillie James
Perini Giovanni
Scriptgen Pharmaceuticals Inc.
University of Massachusetts Medical Center
Williams Jay
Wortman Donna C.
LandOfFree
Methods for screening for inhibitors of the transcription-enhanc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for screening for inhibitors of the transcription-enhanc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for screening for inhibitors of the transcription-enhanc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2335238